T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker-Reference-Cited by-同舟云学术

T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarker

Published:2017-03-06 Issue:11 Volume:140 Page:2535-2544
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Akyüz Nuray¹,Brandt Anna¹,Stein Alexander¹,Schliffke Simon¹,Mährle Thorben¹,Quidde Julia¹,Goekkurt Eray²,Loges Sonja¹,Haalck Thomas³,Ford Christopher Thomas¹,Asemissen Anne Marie¹,Thiele Benjamin¹,Radloff Janina¹,Thenhausen Toni⁴,Krohn-Grimberghe Artus⁴⁵,Bokemeyer Carsten¹,Binder Mascha¹

Affiliation:

1. Department of Oncology and Hematology, BMT with section Pneumology; Hubertus Wald Tumorzentrum/UCCH, University Medical Center Hamburg-Eppendorf; Hamburg Germany

2. Hämatologisch-Onkologische Praxis Eppendorf (HOPE); Hamburg Germany

3. Department of Dermatology; Hubertus Wald Tumorzentrum/UCCH, University Medical Center Hamburg-Eppendorf; Hamburg Germany

4. LYTIQ GmbH; Paderborn Germany

5. Analytische Informationssysteme und Business Intelligence, Universität Paderborn; Paderborn Germany

Funder

Annemarie Hilgemann foundation

Hubertus Wald foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference38 articles.